Rapid resolution of pyoderma gangrenosum after treatment with intravenous cyclosporine - 24/04/13
Doi : 10.1016/j.jaad.2009.11.683
Ryan B. Turner, MD a, Jason J. Emer, MD b, ⁎ 
, Merav Weill, BS b, Laura Winterfield, MD c, Sonia Friedman, MD d, Abrar A. Qureshi, MD, MPH c
, Merav Weill, BS b, Laura Winterfield, MD c, Sonia Friedman, MD d, Abrar A. Qureshi, MD, MPH c a Division of Dermatology, Albert Einstein College of Medicine, New York, New York
b Department of Dermatology, Mount Sinai School of Medicine, New York, New York
c Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts
d Department of Gastroenterology, Brigham and Women’s Hospital, Boston, Massachusetts
Reprint requests: Jason J. Emer, MD, Mount Sinai School of Medicine, Department of Dermatology, 5 E 98th St, 5th floor, New York, NY 10029.| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2010
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 63 - N° 3
P. e72-e74 - septembre 2010 Retour au numéro
Article précédent
- Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis
- Johanna M. Kwakkel-van Erp, Inge M. Haeck, Annelieke W.M. Paantjens, Ed A. van de Graaf, Walter G.J. van Ginkel, Mirjam J. Knol, Marjolein S. de Bruin-Weller, Jan-Willem J. Lammers, Edward F. Knol, Carla Bruijnzeel-Koomen, Henny G. Otten
- Basal cell carcinoma and atypical fibroxanthoma: An unusual collision tumor
- Rubina Alves, Juan Ocaña, Esmeralda Vale, Susete Correia, Isabel Viana, Olívia Bordalo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?